BIOA vs OMC · rev $9.0M vs rev $17.27B
BioAge Labs, Inc (BIOA) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
BIOA currently screens at market cap $697.9M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the BIOA and OMC stock pages for the full models.
Not investment advice.